Skip to main content
. 2022 Aug 22;10(8):2047. doi: 10.3390/biomedicines10082047

Figure 3.

Figure 3

For cell-free DNA or RNA screening, the blood sample is taken from the patient and analyzed through techniques, such as qPCR, NGS WGS, etc. The non-invasiveness of a liquid biopsy makes it suitable for a myriad of applications, including cancer diagnoses, tumor burden analyses, and therapeutic analyses.